Cytomed Therapeutics Stock Forecast

Sell candidate since Jul 27, 2026

The Cytomed Therapeutics Limited stock price fell by -9.11% on the last day (Monday, 27th Jul 2026) from $0.99 to $0.90. During the last trading day the stock fluctuated 12.84% from a day low at $0.84 to a day high of $0.95. The price has fallen in 6 of the last 10 days and is down by -6.31% for this period. Volume has increased on the last day by 158 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 181 thousand shares were bought and sold for approximately $162.83 thousand.

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Cytomed Therapeutics Limited stock with a 90% probability to be traded between $0.711 and $1.31 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

GDTC Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Cytomed Therapeutics Limited stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.95 and $1.03. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, May 20, 2026, and so far it has fallen -31.83%. Further fall is indicated until a new bottom pivot has been found. Cytomed Therapeutics Limited gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Cytomed Therapeutics Limited stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.81 and $0.780. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Cytomed Therapeutics Limited finds support just below today's level at $0.81. If this is broken, then the next support from accumulated volume will be at $0.780 and $0.723.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.108 between high and low, or 12.84%. For the last week, the stock has had daily average volatility of 8.07%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (GDTC) For The Upcoming Trading Day Of Tuesday 28th

For the upcoming trading day on Tuesday, 28th we expect Cytomed Therapeutics Limited to open at $0.90, and during the day (based on 14 day Average True Range), to move between $0.86 and $0.94, which gives a possible trading interval of +/-$0.0789 (+/-9.17%) up or down from last closing price. If Cytomed Therapeutics Limited takes out the full calculated possible swing range there will be an estimated 9.17% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.99 (10.02%) than the support at $0.81 (10.09%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Cytomed Therapeutics Limited stock A Buy?

Cytomed Therapeutics Limited holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -3.676 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 28, 2026 - $0.90 ( 0.426%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk